MedPath

Information Technology for Hypertension and Diabetes Care in Government Health System

Not Applicable
Conditions
Health Condition 1: E08-E13- Diabetes mellitusHealth Condition 2: I10-I16- Hypertensive diseases
Registration Number
CTRI/2020/01/022723
Lead Sponsor
All India Institute of Medical Sciences AIIMS
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

This is not a traditional trial in which we will enroll patients. Instead, investigators will be provided with de-identified data of all patients who seek care for hypertension and/or diabetes in a government health facility within the intervention block. Because the data are collected in the course of providing routine care to patients, no additional criteria apply.1)All adults seeking diagnosis of, or care for, hypertension or diabetes at a public health facilities in the intervention block

Exclusion Criteria

None

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Difference in the mean change in systolic blood pressure from baseline and at 3 year after intervention initiation at the community-level between the I-TREC and comparison block among patient with hypertension. Please note that these data will come from a strictly observational survey conducted in the community.Timepoint: 2 i.e at baseline and at 3 years
Secondary Outcome Measures
NameTimeMethod
Difference between I-TREC and comparison block at baseline and at 3 years after intervention initiation: <br/ ><br>1.In the mean change in fasting plasma glucose at the community-level among patient with type-2 diabetes <br/ ><br>2.Percent of individuals with hypertension and diabetes who have controlled blood pressure and blood sugar, respectively <br/ ><br>3.In mean change in systolic blood pressure and fasting plasma glucose among patients who are observed more than once in the health facilities <br/ ><br>Timepoint: 2 i.e at baseline and at 3 year
© Copyright 2025. All Rights Reserved by MedPath